Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression

NCT00472576 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00472576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00472576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2007
Completion date
August 31, 2009
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression